September 19th, 2013

How do cloud and middleware mix? For Novartis, what appeared initially as a challenge to overcome proved instead to be pretty compelling features of the platform.

This afternoon we were able to share the Novartis story with a wider audience, on our final customer-story #BoomiWebinar of the
season. The topic was “cloud-speed” integration in a highly regulated
environment. How do you use a cloud model in your middleware solution—so that
you get those cloud advantages of flexibility, ease of adoption, lower capital
costs, and so forth—while maintaining complete risk and information compliance?

The answer might surprise you. Thomas Barton at Novartis
dealt with this question both technically and institutionally. Head of
integration services at the $56 billion-per-year global pharmaceutical company,
Thomas had to both validate Boomi’s security
features and architecture, and circle the globe
to get assurance and approval from stakeholders. They were understandably
concerned about having their applications entwine with an integration product that
has “cloud-enabled” stamped on it.

But what appeared initially as a challenge to overcome proved
instead to be pretty compelling features of the platform. As Thomas put it on
the webinar, the Dell Boomi option proved “even more secure than traditional middleware
because the development environment is segregated from your actual
infrastructure.” There was no need to provide access to the Novartis infrastructure
to outside contractors so they could develop and test; they simply used Dell Boomi in their web browsers, from anywhere in the world.

The point is that the “cloud parts” of Dell Boomi are focused
in the development phase of your integrations (as well as in management of them,
once deployed)—where you aren’t using sensitive data, and also where you happen
to most need cloud benefits.

That’s not what you most need in your production environments, though. There, you are
using sensitive data, and your first priority really is control. If you don’t
want any production integration in the cloud, if you need all of it to be in
the cloud, or if you are using a hybrid approach like Novartis does—the
middleware solution should be usable in any of these scenarios. And this is exactly
how the AtomSphere architecture works. So if you think about it, it’s actually by
limiting the use of cloud that Dell Boomi lets you take advantage of it.